Intravitreal brolucizumab in neovascular age-related macular degeneration with limited response to aflibercept

被引：0
|
作者：
Hatz, Katja B. [1 ,2 ]
Cedro, Luca [1 ]
机构：
[1] Vista Klin AG, Binningen, Switzerland
[2] Univ Basel, Basel, Switzerland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Course of Neovascular Age-related Macular Degeneration that Showed Limited Response to Both Ranibizumab and Aflibercept
    Yun, Jeong Seop
    Kim, Chul Gu
    Kim, Jong Woo
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2023, 64 (04): : 313 - 322
  • [32] Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration
    Mehta, Neesurg
    Fong, Rodney
    Wilson, Machelle
    Moussa, Kareem
    Emami-Naeini, Parisa
    Moshiri, Ala
    Yiu, Glenn
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 657 - 665
  • [33] Outcome of Aflibercept-Bevacizumab Alternate Dosing in Neovascular Age-related Macular Degeneration with Limited Response to Aflibercept
    Shin, Daeun
    Kim, Jae Hui
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2022, 63 (06): : 526 - 534
  • [34] Predictive factors for non-response to intravitreal aflibercept treatment in neovascular age-related macular degeneration
    Nagai, Norihiro
    Suzuki, Misa
    Uchida, Atsuro
    Kurihara, Toshihide
    Kamoshita, Mamoru
    Minami, Sakiko
    Shinoda, Halme
    Tsubota, Kazuo
    Ozawa, Yoko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [35] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [36] Tolerating subretinal fluid in the treatment of neovascular age-related macular degeneration with intravitreal aflibercept
    Yildiz, Dilan
    Cakir, Akin
    Erden, Burak
    Bolukbasi, Selim
    Erdenoz, Serkan
    Elcioglu, Mustafa Nuri
    THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2021, 13
  • [37] Morphological changes with Intravitreal Aflibercept for Treatment Resistant Neovascular Age-Related Macular Degeneration
    Wong, Lily
    Le Hong, Thomas Hai
    Broadhead, Geoffrey
    Zhu, Meidong
    Chang, Andrew Alexander
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [38] Characteristics of patients with neovascular age-related macular degeneration who are nonresponders to intravitreal aflibercept
    Hara, Chikako
    Wakabayashi, Taku
    Toyama, Hiroshi
    Fukushima, Yoko
    Sayanagi, Kaori
    Sato, Shigeru
    Sakaguchi, Hirokazu
    Nishida, Kohji
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2019, 103 (05) : 623 - 629
  • [39] HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration
    Brown, David M.
    Nowik, Marta
    Bouillaud, Emmanuel
    Dugel, and Pravin U.
    CURRENT EYE RESEARCH, 2023, 48 (01) : 44 - 50
  • [40] Bilateral occlusive vasculitis after intravitreal injection of brolucizumab in neovascular age-related macular degeneration
    Riedel, Anna Maria
    Lackerbauer, Carlo
    Lohmann, Chris P.
    Ulbig, Michael
    OPHTHALMOLOGE, 2022, 119 (01): : 75 - 78
12345